Pulse Biosciences (PLSE) Institutional Ownership
13F filers reported holding 4.3% of Pulse Biosciences (PLSE) shares as of Sep 30, 2026, across 74 filers.
- Held by 13F filers
- 4.3%
- Sep 30, 2026
- 13F filers
- 74
- quarter ended Sep 30, 2026
- 13F value
- $157.9M
- 3.2M shares
- Quarter's fund flow
- Mild accumulation
- 21 new · 3 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Acquired · Open-market buy | 1,001 | $49.95 | ↗ |
| Aug 31, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Acquired · Open-market buy | 1,024 | $48.80 | ↗ |
| Aug 28, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Acquired · Open-market buy | 1,034 | $48.35 | ↗ |
| Aug 26, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Acquired · Open-market buy | 1,036 | $48.24 | ↗ |
| Aug 8, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Acquired · Grant / award | 200,000Restricted Stock Units | — | ↗ |
| Aug 8, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Acquired · Grant / award | 700,000Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Zanganeh Maky | director | Acquired · Grant / award | 30,000Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Zanganeh Maky | director | Acquired · Grant / award | 14,504Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | van den Broek Richard | director | Acquired · Grant / award | 30,000Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | van den Broek Richard | director | Acquired · Grant / award | 8,423Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | DUGGAN ROBERT W | director | Acquired · Grant / award | 30,000Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | DUGGAN ROBERT W | director | Acquired · Grant / award | 12,495Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Soni Manmeet Singh | director | Acquired · Grant / award | 30,000Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Sainz Maria | director | Acquired · Grant / award | 30,000Stock Option (right to buy) | — | ↗ |
| Jun 11, 2026 | Sainz Maria | director | Acquired · Grant / award | 3,793Stock Option (right to buy) | — | ↗ |
| May 11, 2026 | DUGGAN ROBERT W | director | Acquired · Open-market buy | 660,233 | $19.69 | ↗ |
| May 11, 2026 | LAVIOLETTE PAUL A | Chief Executive Officer | Acquired · Open-market buy | 15,000 | $19.69 | ↗ |
| May 11, 2026 | LAVIOLETTE PAUL A | Chief Executive Officer | Acquired · Open-market buy | 15,000 | $19.69 | ↗ |
| May 11, 2026 | DUGGAN ROBERT W | director | Acquired · Open-market buy | 660,233 | $19.69 | ↗ |
| Mar 23, 2026 | UECKER DARRIN | Chief Technology Officer | Acquired · Grant / award | 100,000Restricted Stock Units | — | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Pulse Biosciences do institutions hold?
13F filers reported holding 4.3% of Pulse Biosciences' shares as of Sep 30, 2026, across 74 filers.
How many 13F filers hold Pulse Biosciences?
Pulse Biosciences was held by 74 13F filers as of Sep 30, 2026.
Not investment advice.

